Filing Details
- Accession Number:
- 0000899243-20-015822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-09 16:44:32
- Reporting Period:
- 2020-06-05
- Accepted Time:
- 2020-06-09 16:44:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1463361 | Unity Biotechnology Inc. | UBX | Pharmaceutical Preparations (2834) | 264726035 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1559531 | E Nathaniel David | C/O Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco CA 94080 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2020-06-05 | 3,200 | $8.90 | 2,327,186 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices vary between $8.8994 and $8.8995 per share. Information on the exact number of shares purchased at each purchase price can be obtained from Issuer upon request.
- Includes Restricted Stock Units which vest over time measured from the grant date.
Billionaire Hedge Funds
